Tuesday, 15 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Deals
Arctic Vision-Mdco Technology Merger Builds Ophthalmology Platform
February 3, 2026
Company
Eli Lilly to Invest $3.5B in Pennsylvania Plant for Retatrutide Production
February 3, 2026
Company
Drug
Eli Lilly Mounjaro Fails to Win EU Approval for HFpEF Heart Failure Indication
February 3, 2026
Company
Drug
Imfinzi Gastric Cancer: AstraZeneca Secures CHMP Recommendation
February 3, 2026
Company
Drug
Chiesi’s Juxtapid Wins NMPA Approval for Rare Cholesterol Disorder in China
February 3, 2026
Company
Deals
SanegeneBio Partners with Genentech on RNAi Therapy in $1.7B Deal
April 10, 2026
Company
Deals
Zonsen Peplib Signs Eli Lilly Deal After Novartis Partnership
February 3, 2026
Company
Drug
Novartis Cosentyx Wins NMPA Approval for Non-Radiographic Axial Spondyloarthritis
February 3, 2026
Company
Deals
WuXi Biologics Partners with Vertex on Trispecific T-Cell Engager for Autoimmune Diseases
February 3, 2026
Policy / Regulatory
NMPA Releases 101st Batch of Generic Reference Drugs
February 2, 2026
Company
Deals
Zenshine Pharma Files for Hong Kong IPO with $357M Valuation
February 2, 2026
Company
Deals
Moderna Partners with Recordati on mRNA-3927 for Rare Propionic Acidemia
February 2, 2026
1
2
…
169
170
171
172
173
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?